2026 NPPES data Pulmonary Disease Physician NPI 1275580185 MD
Verify on CMS →

ALAN BAKST, MD

Pulmonary Disease Physician in ATLANTIS, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 409 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$606.18
22 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ALAN BAKST, MD is a Pulmonary Disease Physician ([object Object]) practicing in ATLANTIS, Florida with a Medicare Part D prescribing footprint of 2K claims across 409 beneficiaries — 55% brand-name prescribing . Industry payments of $606.18 across 22 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ALAN BAKST, MD filed 2,189 Medicare Part D claims in 2023 across ATLANTIS, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ALAN BAKST, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ALAN BAKST, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/27/2006

NPI 1275580185

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

2,189 50% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Florida

How Pulmonary Disease Physician compares to other specialties among Florida providers

Florida providers

Pulmonary Disease Physician share within Florida

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALAN BAKST, MD is a Pulmonary Disease Physician provider practicing in ATLANTIS, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1275580185. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ALAN BAKST, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 5401 S CONGRESS AVE, ATLANTIS, FL, 33462, with a listed phone of (561) 967-4118. NPI 1275580185 was issued on 05/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAKST most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,189 prescription claims written by this provider, covering 409 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5401 S CONGRESS AVE
ATLANTIS, FL 33462

Provider Details

NPI 1275580185
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 05/27/2006

Hospital and facility affiliations

Facilities where ALAN BAKST, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PULMONARY CRITICAL CARE AND SLEEP
ATLANTIS, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALAN BAKST, MD. Source: openpaymentsdata.cms.gov.

Total received

$606

Largest payer

Inspire Medical Systems, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ALAN BAKST, MD. To verify ALAN BAKST, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ALAN BAKST, MD — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 2,189 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,189
Total Claims
$1.6M
Total Drug Cost
409
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,980
Total Day Supply
79,299
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$1.5M
Antibiotic Claims
152

Patient Demographics

Average Patient Age
76.5 years
Avg HCC Risk Score
2.23
Gender Split
64% female / 36% male
Age Distribution
<65: 22, 65-74: 146, 75-84: 174, 85+: 67

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
417
Prednisone
293
Albuterol Sulfate Hfa
Albuterol Sulfate
233
Breo Ellipta
Fluticasone/Vilanterol
190
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
110
Montelukast Sodium
85
Azithromycin
68
Symbicort
Budesonide/Formoterol Fumarate
64
Ipratropium Bromide
57
Ofev
Nintedanib Esylate
47

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How ALAN BAKST, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

ALAN BAKST, MD's 2,189 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BAKST.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALAN BAKST, MD's specialty?
ALAN BAKST, MD specializes in Pulmonary Disease Physician and practices in ATLANTIS, Florida. Credentials: MD.
How much does ALAN BAKST, MD prescribe under Medicare Part D?
In 2023, ALAN BAKST, MD wrote 2,189 Medicare Part D claims totaling $1.6M in drug costs for 409 beneficiaries.
Where is ALAN BAKST, MD located?
ALAN BAKST, MD is located at 5401 S CONGRESS AVE, ATLANTIS, FL, 33462. Phone: (561) 967-4118.
What is ALAN BAKST, MD's NPI number?
ALAN BAKST, MD's National Provider Identifier (NPI) is 1275580185, issued on 05/27/2006.
Does ALAN BAKST, MD prescribe more brand-name or generic drugs?
ALAN BAKST, MD's prescribing is 55% brand-name and 45% generic drugs by claim count, with $1.5M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does ALAN BAKST, MD prescribe most often?
Based on 2023 Medicare Part D data, ALAN BAKST, MD's most frequently prescribed drugs include Trelegy Ellipta, Prednisone, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALAN BAKST, MD accept Medicare?
ALAN BAKST, MD appears in CMS Medicare data with 2,189 Part D claims and 409 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALAN BAKST, MD's credentials?
ALAN BAKST, MD's NPI is 1275580185 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology